Perigord | Life Science Artwork Solutions

News

Perigord is the global leader in the provision of high quality artwork and labelling outsource services and management solutions to the Life Science industries.

Perigord partners with GlobalVision to integrate artwork management solutions.

Wednesday, September 07, 2016

Perigord partners with GlobalVision to integrate artwork management solutions.

Dublin, Ireland, September 7, 2016.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.

Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers.  GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection.  In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.

"We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord.  “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”

Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Mark Ennis

Contact Us

About GlobalVision

GlobalVision is the world leader in the design of innovative proofreading technologies. With over 25 years of experience, we've helped customers increase proofreading accuracy, efficiency, and speed. Our solutions have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 70% of the top pharmaceutical companies worldwide.

Contact

Michael Malz

Contact GlobalVision

Perigord enters new Strategic Partnership with Nathean

Tuesday, June 21, 2016

Perigord partners with Nathean to provide Life Science Artwork Management Software customers with increased levels of performance and superior data-driven decisions.

Dublin, Ireland, 21 June 2016.

Perigord, the global leader in Life Science artwork management services and solutions, recently entered a strategic partnership with data analytics and reporting company Nathean to provide Logix, their Business Intelligence and enhanced KPI Reporting tool, as an integrated feature within Perigord’s Global Artwork Management System (GLAMS).

Life Science companies are constantly facing challenges with the agile and secure management of digital artwork assets and this has become a key strategic focus following the recent increase in mergers and acquisitions.

The partnership between Perigord and Nathean offers Life Science artwork management software customers actionable analytics, granting the capture of extensive amounts of information in easy to view dashboards, tailored views and automated email reports, previously unseen as part of an artwork management software solution.

Speaking of the partnership, Perigord’s Head of Professional Services, Sam Cole says “Perigord are very pleased to work with Nathean to provide informed decision making and planning through our GLAMS Analytics tool.  The Business Intelligence and enhanced KPI Reporting feature provides configurable reporting dashboards enabling faster analysis and reporting, offering GLAMS customers the benefits of deeper and richer business insights. A system such as this which presents visibility and reporting of live artwork data is exactly what our customers have been requesting and we are delighted to now be in a position to offer this as part of our GLAMS offering.”

Maurice Lynch, CEO of Nathean, also comments on the co-operation between Perigord and Nathean noting “Working with a well-established global Life Science partner such as Perigord allows Nathean the opportunity to assist their GLAMS customers by offering an increased return on investment.  By implementing the Business Intelligence and enhanced KPI Reporting feature, GLAMS customers are allowed autonomous and uniformed decision making for all users.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Barbara Murphy

Marketing Manager

Contact Us

About Nathean

Nathean develops Logix, a ground breaking self-service Analytics & Reporting platform designed to effortlessly connect people and information. Every day Logix enables people to discover actionable insights from data helping drive better business outcomes.

Contact

Maurice Lynch

CEO

Contact Nathean

Perigord explains the importance of compliant, validated artwork and labelling solutions in the pharmaceutical sector

Tuesday, April 12, 2016

The number of pharmaceutical product recalls are growing. Some estimates show that over 50% of recalls are related to pharmaceutical packaging artwork and labelling.

How many times have we heard these statistics over the last 20 years? And yet nothing changes.

The bottom line is that if there is an error with pharmaceutical artwork, the patient can die. The absence of regulatory requirements within the pharmaceutical industry regarding the production of artwork is indicative of the lack of focus often given to this process.

There is increased pressure to improve operational performances and reduce the level of human error. If we make it easy for someone to make a mistake, they will. We need to make it easy to get it right first time.

To do this we have to take a realistic look at the challenges faced by the pharmaceutical industry over the next five to ten years which will impact the artwork process and determine what robust innovative measures we should take to ensure these recall figures don’t spiral out of control.

Attitudes towards artwork management within the supply chain need to change. There should be a focus on quality driven systems to enable continuous technological developments facilitate the automation and standardisation required to prevent mistakes.

Industry analysis

Firstly we need to look at some of the key aspects of the pharmaceutical industry that are driving change.

1. Mergers & Acquisitions in the healthcare sector set a new record in 2015 of $724 billion. As a result, the agile and secure management of digital artwork assets has become a key strategic focus. 

2. Serialisation will result in a combination of more artwork content and stricter directives governing readability. This combined with reduced print space will drive an unprecedented demand for regulated artwork services and management systems over the next 5 years. 

3. Product proliferation leads to significantly increased frequency of artworking events and far greater complexities in managing the artworking processes with many companies having reached or exceeded their capability to manage the process internally. 

4. As a result of the patent cliff, a single innovative pharmaceutical product which has lost patent protection is being replaced with new generic products globally, leading to an exponential growth in demand for outsourced artwork solutions. 

What needs to be done?

Why do we accept high levels of inaccuracy when we can standardise how artwork is created and automate how it’s managed?

Pharmaceutical companies need to understand how their present artwork processes should change to facilitate these future drivers. To navigate accurately through these changes a proactive and systematic approach to artwork is crucial. Companies have to ask themselves if the artwork process is clearly defined, optimised and quality driven.

Managing artwork for the pharmaceutical industry is a very specialised, niche service which can only be properly controlled by a GMP compliant partner. If using a vendor, it is critical to develop a partnership to ensure all aspects of the artwork supply chain are controlled and agile to meet the challenges of the industry.

The two fundamental areas which need to be addressed are the physical production of the artwork and the management of the artwork process.

Artwork production 

Perigord recommends a one touch process in building compliant artwork which increases efficiency, reduces costs and minimises risk through fewer stages, thus eliminating the historical prepress stage. Effectively this means that artwork is built to high quality standards (and print ready) and the layer structure and font integrity is maintained throughout the approval cycle. Perigord ensures this process sits in a robust quality management system with a change management procedure that facilitates the efficiencies to be gained through the introduction of automated technology. 

Artwork management systems 

The most obvious way to remove the dangers of human error is to automate. Managing the amount of stakeholders and the input they have in this complex process by email is inconsistent with every company’s objective of getting product to market on time and right first time. This needs to be replaced by a highly configurable system that can be easily adapted to align with a customer's current and future processes, giving the flexibility of a systematic approach to managing products and product related information. 

In summary, reducing the number of recalls in the pharmaceutical industry requires better regulation, improved operational procedures and a change of attitude towards artwork production and management. The challenges that lie ahead have been identified, all we need now is to face them head on, in a controlled GMP fashion.

References

1 - http://www.xtalks.com/Pharmaceutical-Packaging-Management.ashx

2 - http://news.yahoo.com/global-mergers-acquisitions-volume-hits-record-2015-163303085.html 

Release of future proofed Artwork Lifecycle Management System by Perigord leads way for Life Science companies

Thursday, March 31, 2016

Dublin, Ireland, 31 March, 2016.

Perigord has officially launched the latest release of their proprietary innovative software, GLAMS (Global Artwork Management System).  GLAMS 4,  a configurable Software as a Service (SaaS) solution, presents a comprehensive artwork lifecycle management offering, coupled with fully integrated web forms and Business Intelligence Reporting capabilities.

Giving all stakeholders and customers in the artwork management process full control, by linking them through automatic emails and alerts, GLAMS 4’s end-to-end digital workflow allows customers to intelligently search and quickly distribute their artwork assets.

GLAMS - Connecting Stakeholders

GLAMS - Connecting Stakeholders


GLAMS 4 offers a platform for multiple modules and, as it is web based, it is a light touch application, providing future proofed software for Life Science customers.

Keeping the Life Science customer in mind, GLAMS 4 has been developed in compliance with GAMP 5 guidelines, is fully validated and allows 24/7 global access. In addition and in order to deliver a unified environment, GLAMS 4 can be seamlessly integrated to existing ERP/PLM systems.

Speaking of the launch, Perigord’s Head of Professional Services, Sam Cole says “We are delighted to be in a position to launch GLAMS 4. This web based artwork management solution is ready and available to be rolled out in both existing and future GLAMS customers. Our platform is a Configurable Off The Shelf (COTS) solution, enabling exciting upgrades in the future for all customers.

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Barbara Murphy

Marketing Manager

Contact Us

Perigord build platform for global growth with significant investment from BDO Development Capital Fund

Wednesday, February 17, 2016

Dublin, Ireland, 12 February 2016.

Perigord, a leader in the European life science packaging artwork management sector, today announced it has secured a development capital investment from the BDO Development Capital Fund to accelerate the company’s global expansion.  With the life sciences sector now facing post patent cliff complexities (including unprecedented M&A activity, generic drug proliferation and product serialisation to combat counterfeiting) the pharma packaging sector will witness significant growth in the coming 5 year period. 

Perigord secures global funding
From L-R: Andrew Bourg (left), Investment Director, Development Capital, Sinead Heaney, Investment Director, Development Capital, Alan Leamy (right),  CEO, Perigord

Employing over 100 people, Perigord is aiming to lead new developments in the sector.  From its base in Dublin, which services the European market, Perigord plans to upgrade and open the new hubs in America, Asia and Latin America.  This world-wide footprint will facilitate the creation of a global platform to service the life sciences sector and deliver true global solutions. 

The funding for Perigord was secured from the BDO Development Capital Fund, a fund supported by Enterprise Ireland (an Irish Government Agency), Bank of Ireland and leading Irish Corporates CRH, Glanbia and Glen Dimplex. The Fund invests development and growth capital in ambitious companies to support their export growth plans. The funding will be used to build out Perigord’s global network and respond to existing demand to provide artwork solutions under global supply agreements.

Perigord has a clear plan to realise its ambition to globalise the company and achieve a dominant market share in the highly regulated sector in which it operates.  Competing against multinational competitors, Perigord has successfully built strong relationships with many of the world’s leading global pharmaceutical businesses and the company’s sole focus on the pharma and life sciences industry has enabled it to achieve a compelling competitive market position.

Speaking about the company’s plans, Perigord CEO, Alan Leamy said:

"This investment from the BDO Development Capital Fund will enable us to build on the success achieved to date which is thanks to our team of highly talented & committed people in Perigord, the external support of Enterprise Ireland and the support of our customers.  We look forward to working with our new partners in Development Capital to increase our global scale and service the global life sciences sector as it goes through significant changes in the coming 5 year period.

We have a proven track record with some of the world’s leading pharma companies and we can now build on our European success with expansion right across the world."

Also speaking was Sinead Heaney, Investment Director, Development Capital, who said:

"The BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. Perigord has all these qualities and we look forward to our partnership to assist them achieve their international expansion plans."

Helen Ryan, former CEO of Creganna who is an Advisory Panel Member of the BDO Development Capital Fund also commented

"Perigord is an excellent example of the type of company the fund is seeking to support. The life science sector is experiencing significant growth and we look forward to working with Perigord to unlock this growth potential by assisting the company to build a truly global network."


Contact

 

Barbara Murphy

Marketing Manager

Contact Us



Perigord showcases rebrand, dynamic new website and revamped logo

Wednesday, October 28, 2015

Dublin, Ireland, October 28, 2015.

Perigord, an Irish owned Life Science artwork and labelling outsource services and management solutions provider, are delighted to announce the launch of their new brand identity, dynamic website and updated logo.

Perigord’s focus has long been on the Life Science Industries, with their strengths lying in its pharmaceutical knowledge, its high quality standards and commitment to customer satisfaction.  This rebranding exercise illustrates Perigord’s ongoing pledge to their Life Science customers, assisting them with the delivery of quality artwork, operational excellence and GMP compliant processes, whilst keeping production costs at a minimum.


“Our rebranding reflects the next phase of Perigord’s evolution with the new logo representing our three pillar offering: Artwork Services, Artwork Process Solutions and Artwork Management Software (GLAMS) for the Life Science Industries,” says Alan Leamy, CEO. “This decision to rebrand also ties into our current expansion, as we strive to become the number one artwork solutions provider to the Life Science Industries.”

The redesigned website demonstrates a fresh approach for Perigord, utilising a responsive, easy to navigate design, with a strong pharmaceutical theme running throughout.

 

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally.  Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle.  Connecting all stakeholders in the process, GLAMS has been developed to GAMP 5 standards, is fully validatable and allows 24/7 global access.

www.perigord-as.com

 

Contact

 

Barbara Murphy

Marketing Manager

Contact Us 

 



Effective Artwork Management Key to Reducing the Risk of Pharmaceutical Product Recall.

Friday, September 09, 2011

Dublin, Ireland, September, 2011.

It has been well documented that the costs associated with pharmaceutical packaging can represent up to 70% of the cost of the finished product. In addition industry experts estimate that between 35 to 40 percent of all pharmaceutical product recalls are attributed to packaging and labeling errors and omissions. In fact, a recent report by AMR Research revealed that in a six-month period last year, the Food and Drug Administration statistics include 455 product recall notices, 51 percent of which were because of mislabeling, and 13 percent were because of faulty packaging.

In terms of artwork and packaging, expanding global markets mean pharmaceutical companies need to deal with localization issues such as language, cultural and regulatory requirements. The scramble for entry into the pharmerging markets, a phrase coined by market intelligence organisation IMS Health to describe emerging pharmaceutical markets, has also offered up some unique challenges.

Right First Time artwork and packaging can be crucial to entry into a new market or indeed the overall commercial success of a drug. Using the Perigord Group’s Artwork services and technology, GLAMS or Global Artwork Management System, companies can effectively manage and connect all stakeholders in the process including regulatory, marketing, affiliates, multiple artwork centers (both internal and external), approvers, procurement and print vendors.

GLAMS is a web-based Artwork Management System that was developed to manage and streamline the artwork process from concept through to printing. It places total control over artwork in the customer’s hands, enabling better management of costs and accelerating the customer’s time to market.

What’s more, GLAMS creates a central online storage area that accepts all files using recognized industry standards, to provide a single point of proof. GLAMS allows all involved parties to participate directly in the print production process to generate artwork in a unified tracking and management flow. GLAMS integrates with all aspects of the artwork life cycle according to and in compliance with relevant industry standards and the customer’s specific needs.

Autumn Releases

Perigord are set to unveil the latest features of GLAMS this autumn at events in London and Munich.

• Pharma Packaging and Labelling Europe 2011, 19th & 20th Sept, Munich, Germany.
• Pharma Labelling, 19-20th Oct, Covent Garden, London.
• Pharmaceutical Packaging and Labelling event, 2-3rd Nov, London.

Commenting on the new releases, Alan Leamy, Perigord Group, Chief Executive Officer said, “We’re looking forward to showcasing some exciting new features of GLAMS. Unlike other products in the market, our system has been validated and we believe this makes it a unique and best in class solution.

About Perigord

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle.  Connecting all stakeholders in the process, GLAMS has been developed to GAMP 5 standards, is fully validatable and allows 24/7 global access.

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally.  Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

www.perigord-as.com

 

Contact

Barbara Murphy

Marketing Manager

 

 


Recent Posts


Tags


Archive

Centralised Global QMS Certified to ISO 9001:2015 & PS 9000:2016